Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cervical cancer burden and elimination readiness in the US-affiliated Pacific Islands: A structured narrative review.

Cancer epidemiology·2026
Same author

Brief Report: Mammogram Rates Among Women With and Without HIV in a Large Integrated Health Care System.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Disseminated BCGosis After Intravesical BCG Installation for Bladder Cancer.

Case reports in infectious diseases·2025
Same author

HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial.

The lancet. HIV·2024
Same author

Breast cancer incidence and stage at diagnosis in the six US-Affiliated Pacific Islands.

Cancer epidemiology·2024
Same author

Building Capacity for Cervical Cancer Prevention in U.S.-Affiliated Pacific Islands: The Pacific Against Cervical Cancer Project.

Journal of women's health (2002)·2024
Same journal

UH Cancer Center Hotline: the training and education program of the University of Guam/University of Hawai'i Cancer Center Partnership.

Hawaii medical journal·2012
Same journal

An assessment of the Pacific Regional Cancer Coalition: outcomes and implications of a regional coalition internal and external assessment.

Hawaii medical journal·2012
Same journal

Higher percent body fat in young women with lower physical activity level and greater proportion Pacific Islander ancestry.

Hawaii medical journal·2012
Same journal

Cancer mortality following polychlorinated biphenyl (PCB) contamination of a Guam village.

Hawaii medical journal·2012
Same journal

Needs and experiences of Samoan breast cancer survivors in Southern California.

Hawaii medical journal·2012
Same journal

Local food policies can help promote local foods and improve health: a case study from the Federated States of Micronesia.

Hawaii medical journal·2012
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Viral hepatitis in Hawai'i--differing perspectives.

Alan D Tice1, Michael Bannan, Kay Bauman

  • 1University of Hawai'i John A Burns School of Medicine, Honolulu, HI, USA. alantice@idlinks.com

Hawaii Medical Journal
|June 10, 2010
PubMed
Summary
This summary is machine-generated.

Conferences in Hawai'i addressed the silent epidemic of viral hepatitis, bringing together healthcare professionals and patients. The goal was to increase awareness and foster a collaborative approach to managing hepatitis challenges in the state.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Experiment Videos

Last Updated: Jun 12, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Area of Science:

  • Hepatology
  • Public Health
  • Epidemiology

Background:

  • Viral hepatitis presents a significant public health challenge in Hawai'i.
  • Conferences were convened to address the "silent epidemic" of viral hepatitis.
  • The Hepatitis Support Network of Hawai'i has been instrumental in organizing these events.

Purpose of the Study:

  • To heighten awareness of viral hepatitis specific to Hawai'i.
  • To convene healthcare professionals for education on viral hepatitis.
  • To develop a team-based approach to managing hepatitis challenges.

Main Methods:

  • Information compiled from conferences held in October 2007, 2008, and 2009.
  • Conferences sponsored by the Hepatitis Support Network of Hawai'i.
  • Held at the Queen's Conference Center in Honolulu, Hawai'i.

Main Results:

  • The initial conference focused on diverse perspectives from patients and healthcare providers.
  • Subsequent conferences provided updates and additional contributions.
  • Emphasis was placed on understanding individual roles in addressing the epidemic.

Conclusions:

  • A multidisciplinary, team-based approach is crucial for combating viral hepatitis.
  • Increased awareness and professional collaboration are key to managing hepatitis in Hawai'i.
  • Addressing the unique challenges of viral hepatitis requires a coordinated community effort.